News

Endosonography Plus Surgical Staging for NSCLC Halves Unneeded Thoracotomy

View on the News

Surgical Staging Remains the Gold Standard

The main question raised by this study is not whether endosonography improves the sensitivity of surgical staging but whether the combined approach can be translated into a larger patient population and yield equivalent outcomes there, according to Dr. Mark D. Iannettoni.

The level of expertise in endoscopic techniques was likely much higher at the referral centers in this study than it is at community hospitals where most thoracic surgery takes place. "This fact is extremely important because these modalities are highly operator dependent," he noted.

"Until this modality can be reproduced at all centers where thoracic surgery is commonly performed, or until all of these patients are cared for at specialized centers, surgical staging must remain the gold standard for adequate preoperative evaluation," he said.

Mark D. Iannettoni, M.D., is in cardiothoracic surgery at the University of Iowa Heart and Vascular Center, Iowa City. He reported that he had no financial disclosures. These comments were taken from his editorial accompanying Dr. Annema’s report (JAMA 2010;304:2296-7).


 

FROM JAMA

For patients with suspected non–small-cell lung cancer, adding endosonography before surgical staging improves detection of mediastinal nodal metastases, thus reducing unnecessary thoracotomies by more than half, according to a report in the Nov. 24th issue of JAMA.

In addition, because endosonography is minimally invasive, adding this step doesn’t raise the rate of complications for staging procedures, said Dr. Jouke T. Annema of Leiden (the Netherlands) University Medical Center and associates.

The researchers compared surgical staging alone to endosonography followed by surgical staging because "at present it is not known whether initial mediastinal tissue staging of lung cancer by endosonography improves the detection of nodal metastases." Failure to detect such metastases during staging results in patients undergoing thoracotomy for tumor resection, only to have the thoracotomy aborted when unresectable or metastatic lung disease is discovered.

The investigators randomized 241 patients suspected of having resectable NSCLC, who were treated at four tertiary referral centers in Belgium, the Netherlands, and the United Kingdom. Patients were assigned to surgical staging alone, which is the current standard of care (118 subjects), or to endosonography followed by surgical staging (123 subjects).

The sensitivity of surgical staging alone was 79%. This improved to 94% when endosonography was combined with surgical staging, Dr. Annema and colleagues said (JAMA 2010;304:2245-52).

Mediastinal nodal metastases were found in 41 of 118 patients (35%) by surgical staging alone, compared with 62 of 123 patients (50%) by the combined approach. This means that there were 21 unnecessary thoracotomies with surgical staging alone, for a rate of 18%, compared with 9 with the combined approach, for a rate of 7%.

The complication rate was 6% for surgical staging, compared with 1% for endosonography.

These findings show that endosonography improves the sensitivity of surgical staging, halves the rate of unnecessary thoracotomy, and has a low complication rate. Because it also does not require general anesthesia and has been shown in previous studies to be cost effective as well as preferred by patients, "endosonography should be the first step for mediastinal nodal staging," the investigators said.

They added that all of the staging procedures in this study were performed in specialty centers by highly trained and experienced interventionists, so the applicability of the study findings to other settings is limited.

The study was supported in part by Hitachi Medical Systems, COOK, Olympus, the Zorgprogramma Oncologie Gent, the U.K. National Health Service R & D Health Technology Assessment Program, and the National Institute for Health Research Cambridge Biomedical Research Centre.

Recommended Reading

One-Third of Medicare Patients With Cancer Die in Hospitals
MDedge Internal Medicine
OncoMap Gene Sequencing Finds 50 Mutations in Ovarian Tumors
MDedge Internal Medicine
Link Between Physical Illness and PTSD Remains Underrecognized
MDedge Internal Medicine
Can Bundled Cancer-Care Payments Save a Bundle?
MDedge Internal Medicine
FDA Committee Considers Gardasil for Anal Cancer Prevention
MDedge Internal Medicine
FDA Panel Divided on Melanoma Diagnosis Aid
MDedge Internal Medicine
FDA Approves Denosumab for Bone Metastases
MDedge Internal Medicine
Wide Screening for Lynch Syndrome Seen as Cost Effective
MDedge Internal Medicine
Patients Lukewarm on Cosmetic Outcomes After Breast-Conserving Surgery
MDedge Internal Medicine
Cediranib Falls Short in Phase III Glioblastoma Trial
MDedge Internal Medicine